- Ticker
- ABCL
- Price
- 7.31
- Stock movement down
- -0.31 (-4.07%)
- Company name
- Abcellera Biologics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Plafon de piață
- 2.09B
- Valoare intrare
- 2.02B
- Preț/Vânzări
- 3.47
- Preț/Contabilitate
- 1.67
- Randament div
- -
- Creștere div
- -
- Ani de creștere
- -
- Încasare FCF
- -
- Trailing P/E
- 8.42
- Înainte P/E
- -
- PEG
- -
- Creștere EPS
- -
- rentabilitate de 1 an
- -17.12%
- rentabilitate pe 3 ani
- -
- rentabilitate pe 5 ani
- -
- rentabilitate 10 ani
- -
Ultima actualizare: 2023-03-22
AbCellera is pledging to discover promising antibodies for its clients and bring them to the clinic faster than anybody else. Read more about ABCL and the challenges it faces.
24 martie 2023
iO Charts is a Seeking Alpha partner
Today, we take a deeper look at AbCellera Biologics whose Covid revenue stream is fading fast as the pandemic ends. Click here to see our take on ABCL stock.
23 martie 2023
iO Charts is a Seeking Alpha partner
DIVIDENDE
ABCL nu plătește dividende sau nu au fost primite date
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
22 martie 2023
iO Charts is a Seeking Alpha partner
The following slide deck was published by AbCellera Biologics Inc.
22 februarie 2023
iO Charts is a Seeking Alpha partner
VALUATION
Rapoarte de evaluare
Loading...
Date rapoarte de evaluare
| Trailing P/E | 8.42 |
| Preț la OCF | 9.10 |
| Preț la FCF | 13.07 |
| Preț la EBITDA | 5.54 |
| EV la EBITDA | 5.35 |
Evaluare (Vânzări/Valoare contabilă)
Loading...
Date de evaluare (Vânzări/Valoare contabilă)
| Preț la vânzări | 3.47 |
| Preț de rezervare | 1.67 |
| EV la vânzări | 3.35 |
AbCellera Biologics Inc. (NASDAQ:NASDAQ:ABCL) Q4 2022 Earnings Conference Call February 21, 2023 5:00 PM ETCompany ParticipantsTryn Stimart - Chief Legal and Compliance OfficerCarl Hansen -...
22 februarie 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
21 februarie 2023
iO Charts is a Seeking Alpha partner
FINANCIARE
Pe acțiune
Loading...
Date per acțiune
| Număr de acțiuni curente | 286.10M |
| EPS (TTM) | 0.79 |
| FCF pe acțiune (TTM) | 0.51 |
Declarație de venit
Loading...
Date din declarația de venit
| Venituri (TTM) | 603.21M |
| Profit brut (TTM) | 516.44M |
| Venituri din exploatare (TTM) | 335.84M |
| Venit net (TTM) | 248.36M |
| EPS (TTM) | 0.79 |
| EPS (1 an înainte) | -0.45 |
Margini
Loading...
Date margini
| Marjă brută (TTM) | 85.61% |
| Marjă operațională (TTM) | 55.68% |
| Marja de profit (TTM) | 41.17% |
Bilanț
Loading...
Creați un cont gratuit sau conectați-vă pentru a accesa această diagramă
Date bilanț
| Numerar | 371.97M |
| Creanțe nete | 105.96M |
| Total active curente | 1.05B |
| Fond comercial | 47.81M |
| Imobilizări necorporale | 142.55M |
| Imobilizări corporale | 0.00 |
| Total active | 1.55B |
| Creanțe | 9.32M |
| Datoria pe termen scurt/curent pe termen lung | 76.11M |
| Total datorii curente | 106.05M |
| Total datorii | 302.24M |
| Capitaluri proprii | 1.25B |
| Imobilizări corporale nete | 1.06B |
Flux de numerar
Loading...
Creați un cont gratuit sau conectați-vă pentru a accesa această diagramă
Date flux de numerar
| Flux de numerar operațional (TTM) | 229.74M |
| Cheltuieli de capital (TTM) | 69.76M |
| Flux de numerar liber (TTM) | 159.98M |
| Dividende plătite (TTM) | 0.00 |
Rentabilități financiare
Loading...
Creați un cont gratuit sau conectați-vă pentru a accesa această diagramă
Date privind rentabilitatea financiară
| Rentabilitatea capitalului propriu | 19.87% |
| Rentabilitatea activelor | 16.00% |
| Rentabilitatea capitalului investit | 19.79% |
| Rentabilitatea în numerar a capitalului investit | 12.75% |
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
20 februarie 2023
iO Charts is a Seeking Alpha partner
In this article, I will provide my valuation model for AbCellera, building on an article I wrote over a year ago. See why I'm fervently bullish on ABCL stock.
5 ianuarie 2023
iO Charts is a Seeking Alpha partner
INFORMAȚII PRIVIND acțiunile
Grafic acțiuni
Loading...
Date privind prețul acțiunilor
| Deschis | 7.69 |
| Maxim zilnic | 7.70 |
| Minim zilnic | 7.30 |
| Volum zilnic | 1.18M |
| Maximul tuturor timpurilor | 53.20 |
| Estimare analist 1 an | 29.20 |
| Beta | -0.24 |
| EPS (TTM) | 0.79 |
| Dividend pe acțiune | - |
| Data ex-div | - |
| Următoarea dată a câștigurilor | 8 May 2023 |
Potențial dezavantaj
Loading...
Date potențial dezavantajoase
| ABCL | S&P500 | |
| Scădere actuală a prețurilor de la cel mai ridicat nivel din toate timpurile | -86.26% | -17.92% |
| Cea mai mare scădere de preț | -89.25% | -56.47% |
| Data celei mai mari scăderi | 11 May 2022 | 9 Mar 2009 |
| Medie scădere de la maxim | -67.13% | -11.51% |
| Timp mediu până la un nou maxim | 114 days | 13 days |
| Timp maxim până la un nou maxim | 539 days | 1805 days |
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
15 decembrie 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
1 decembrie 2022
iO Charts is a Seeking Alpha partner
DETALIILE COMPANIEI
Capitalizarea pieței
2.09B
Categorie Capitalizarea pieței
Mid-cap
Descriere
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Angajați
475
Pagina web
Relații cu investitorii
-
înregistrări SEC
CEO
Țara
USA
Oraș
Tip stoc
-
Stare CCC
-
Frecvența dividendelor
-
EVENIMENTE ȘI PREZENTĂRI
EvenimentePrezentări
Loading...
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
30 noiembrie 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
16 noiembrie 2022
iO Charts is a Seeking Alpha partner
ÎNȚELEGEȚI AFACEREA
Loading...
AbCellera Biologics has multiple high-value opportunities that should become clear in the next few years. Find out why I'm confident in the long-term return potential of ABCL.
9 noiembrie 2022
iO Charts is a Seeking Alpha partner
AbCellera Biologics Inc (NASDAQ:NASDAQ:ABCL) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ETCompany ParticipantsTryn Stimart - Chief Legal and Compliance OfficerCarl Hansen -...
9 noiembrie 2022
iO Charts is a Seeking Alpha partner
ȘTIRI DESPRE COMPANIE
Toate știrileComunicate de presă
If you aspire to one day topple entrepreneurial genius Elon Musk on the net wealth rankings through the equities market exclusively, you’re obviously going to need to conduct heavy research on the sto...
22 martie 2023
VANCOUVER, British Columbia & LONDON, March 22, 2023--AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
22 martie 2023
VANCOUVER, British Columbia, March 14, 2023--AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023
14 martie 2023
Key Insights Given the large stake in the stock by institutions, AbCellera Biologics' stock price might be vulnerable...
12 martie 2023
VANCOUVER, British Columbia, February 23, 2023--AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023
23 februarie 2023
Image source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL)Q4 2022 Earnings CallFeb 21, 2023, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: ...
22 februarie 2023
AbCellera Biologics Inc. (ABCL) delivered earnings and revenue surprises of -1,100% and 62.63%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the ...
21 februarie 2023
VANCOUVER, British Columbia, February 21, 2023--AbCellera Reports Full Year 2022 Business Results
21 februarie 2023
You don’t have to be particularly astute to recognize the importance of the most undervalued biotech stocks to buy. Fundamentally, the enterprises that undergird these names operate on the cutting edg...
2 februarie 2023
VANCOUVER, British Columbia, February 01, 2023--AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023
1 februarie 2023
Pagina următoare
The following slide deck was published by AbCellera Biologics Inc.
8 noiembrie 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from AbCellera Biologics Inc. (ABCL) stock at Seeking Alpha.
8 noiembrie 2022
iO Charts is a Seeking Alpha partner